Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...
Hospital visits in Illinois due to flu are "quite high," with COVID and RSV also circulating. But what are the symptoms of ...
Respiratory illnesses like RSV, COVID-19, flu, and the common cold spike annually. Johns Hopkins experts debunk myths and share prevention tips. While vaccines target RSV, COVID-19, and flu, managing ...